INDRAPRASTHA MEDICAL CORP
Latest filings
Next results: Thu, 29 Oct · Financial Results- Board meeting on Oct 29 to consider Q2 FY27 results · Board & Shareholder Meetings
- Quarterly share dematerialisation compliance certificate submitted to exchanges · Compliance
- AGM results: all 5 resolutions passed, Rs 4 per share dividend declared · Board & Shareholder Meetings
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a multi-specialty hospital in New Delhi under the Indraprastha Apollo Hospital brand, part of the Apollo Hospitals group. The business runs a single hospital services line, which generated Rs. 1,482.51 crore in revenue in FY26, up 9.3% from Rs. 1,356.36 crore the prior year. The cost structure is dominated by other operating expenses at 45.3% of revenue, followed by employee costs at 19.4% and materials at 17.3%; depreciation is 2.9% of revenue and capex runs at 4.0%, reflecting an asset-heavy facility. Net profit for FY26 was Rs. 183.62 crore, EPS of Rs. 20.03, and operating cash flow of Rs. 167.44 crore. The company is promoted by Apollo Hospitals Enterprise, which holds 22,917,500 equity shares, and had total assets of Rs. 991.36 crore at year-end. ICRA has reaffirmed the long-term credit rating at [ICRA]AA(Stable) on Rs. 162.50 crore of rated bank facilities.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
INDRAMEDCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from INDRAPRASTHA MEDICAL CORP's filed financials and exchange disclosures
What does INDRAPRASTHA MEDICAL CORP do?
INDRAPRASTHA MEDICAL CORP is a Healthcare Services company listed on NSE and BSE, trading under the symbol INDRAMEDCO.
Is INDRAPRASTHA MEDICAL CORP profitable?
Yes. Over the trailing twelve months INDRAPRASTHA MEDICAL CORP reported a net profit of ₹188 Cr on revenue of ₹1,524 Cr.
Does INDRAPRASTHA MEDICAL CORP pay a dividend?
Yes. The dividend yield is 1.42% at the current price. It paid out 22% of its profit as dividend in FY26.
Is INDRAPRASTHA MEDICAL CORP debt-free?
Yes. It reported no borrowings on its 31 Mar 2026 balance sheet, and ₹4.93 Cr of cash.
Is INDRAPRASTHA MEDICAL CORP expensive compared with its peers?
On trailing P/E, INDRAPRASTHA MEDICAL CORP ranks 7 of 30 in Hospital — cheaper than 79% of them, against an industry median of 42.0×. This is a position, not a valuation judgement.
How much does the INDRAPRASTHA MEDICAL CORP share price move in a day?
On a typical session INDRAPRASTHA MEDICAL CORP moves 1.40% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are INDRAPRASTHA MEDICAL CORP's next results?
Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track INDRAPRASTHA MEDICAL CORP's announcements?
Every NSE and BSE filing by INDRAPRASTHA MEDICAL CORP appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.